In a major enforcement policy shift, the FDA announced May 6 that it intends to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, drugs and other medical products for import into the United States. “For too long,” Commissioner of Food and Drugs Dr. Martin A. Makary said, “foreign companies have enjoyed a double standard — given ... Read More